{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:33:04Z","timestamp":1773282784894,"version":"3.50.1"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine and Surgery"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.amsu.2020.10.061","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T17:47:56Z","timestamp":1604598476000},"page":"417-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series"],"prefix":"10.1097","volume":"60","author":[{"given":"Ahmed","family":"Mady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8387-1829","authenticated-orcid":false,"given":"Waleed","family":"Aletreby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3731-6047","authenticated-orcid":false,"given":"Basheer","family":"Abdulrahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3320-6297","authenticated-orcid":false,"given":"Mohammed","family":"Lhmdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfateh M.","family":"Noor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh A.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0290-5044","authenticated-orcid":false,"given":"Ibrahim","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman","family":"Alharthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3370-7099","authenticated-orcid":false,"given":"Dimitrios","family":"Karakitsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5099-0714","authenticated-orcid":false,"given":"Ziad A.","family":"Memish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.amsu.2020.10.061_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.amsu.2020.10.061_bib2","series-title":"WHO Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Summary and Literature Update","year":"2014"},{"issue":"18","key":"10.1016\/j.amsu.2020.10.061_bib3","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"China medical treatment expert group for covid-19 clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.amsu.2020.10.061_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.amsu.2020.10.061_bib5","author":"World Health Organization website"},{"issue":"16","key":"10.1016\/j.amsu.2020.10.061_bib7","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"COVID-19 lombardy ICU network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the lombardy region","volume":"323","author":"Grasselli","year":"2020","journal-title":"Italy. JAMA"},{"key":"10.1016\/j.amsu.2020.10.061_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000000824","article-title":"Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study","author":"Deng","year":"2020","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.amsu.2020.10.061_bib9","article-title":"Disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u00a0314 cases from the Chinese center for disease control and","year":"2020","journal-title":"J. Am. Med. Assoc."},{"issue":"15","key":"10.1016\/j.amsu.2020.10.061_bib10","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1021\/acschemneuro.0c00422","article-title":"Lung injury in COVID-19-an emerging hypothesis","volume":"11","author":"Alharthy","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.amsu.2020.10.061_bib11","article-title":"Comment on Hu et al: the cytokine storm and COVID-19","author":"Faqihi","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.amsu.2020.10.061_bib12","doi-asserted-by":"crossref","first-page":"108427","DOI":"10.1016\/j.clim.2020.108427","article-title":"COVID-19 pathophysiology: a review","volume":"215","author":"Yuki","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.amsu.2020.10.061_bib13","doi-asserted-by":"crossref","first-page":"700\u2010704","DOI":"10.1016\/j.jtho.2020.02.010","article-title":"Pulmonary pathology of early\u2010phase 2019 novel coronavirus (COVID\u201019) pneumonia in two patients with lung cancer","volume":"15","author":"Tian","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.amsu.2020.10.061_bib14","doi-asserted-by":"crossref","DOI":"10.7326\/M20-3255","article-title":"Thromboembolic findings in COVID-19 autopsies: pulmonary thrombosis or embolism?","author":"Deshpande","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.amsu.2020.10.061_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","volume":"8","author":"Fox","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.amsu.2020.10.061_bib16","first-page":"1161","article-title":"Deep vein thrombosis in hospitalized patients with coronavirus disease 2019 (COVID-19) in wuhan, China: prevalence, risk factors, and outcome","volume":"10","author":"Zhang","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.amsu.2020.10.061_bib17","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.amsu.2020.10.061_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"issue":"10229","key":"10.1016\/j.amsu.2020.10.061_bib19","doi-asserted-by":"crossref","first-page":"1033\u20101034","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID\u201019: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.amsu.2020.10.061_bib20","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.amsu.2020.10.061_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25964","article-title":"Tocilizumab for the treatment of severe coronavirus disease 2019","author":"Alattar","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.amsu.2020.10.061_bib22","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"6490","key":"10.1016\/j.amsu.2020.10.061_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.amsu.2020.10.061_bib24","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","author":"Liu","year":"2020","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.amsu.2020.10.061_bib25","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.amsu.2020.10.061_bib26","unstructured":"World Health Organization, Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: Interim guidance. https:\/\/www.who.int\/publications-detail\/clinical-management-of-severe-acute-respiratory-infectionwhen- novel-coronavirus-(ncov)-infection-is-suspected."},{"key":"10.1016\/j.amsu.2020.10.061_bib27","series-title":"Interim Guidance","article-title":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases","author":"WHO","year":"2020"},{"issue":"5","key":"10.1016\/j.amsu.2020.10.061_bib28","first-page":"58","article-title":"Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp\/hel real-time reverse transcription-PCR assay validated in vitro and with clinical specimens","author":"Chan","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.amsu.2020.10.061_bib30","article-title":"RECOVERY collaborative group. Dexamethasone in hospitalized patients with covid-19 - preliminary report","author":"Horby","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.amsu.2020.10.061_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2991\/jegh.k.200817.001","article-title":"Helmet continuous positive airway pressure in the treatment of COVID-19 patients with acute respiratory failure could be an effective strategy: a feasibility study","volume":"10","author":"Alharthy","year":"2020","journal-title":"J Epidemiol Glob Health"},{"issue":"2","key":"10.1016\/j.amsu.2020.10.061_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ccc.2016.12.009","article-title":"Ventilator-associated pneumonia: new definitions","volume":"33","author":"Spalding","year":"2017","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.amsu.2020.10.061_bib33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections","volume":"16","author":"Garner","year":"1988","journal-title":"Am. J. Infect. Contr."},{"key":"10.1016\/j.amsu.2020.10.061_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijsu.2018.10.031","article-title":"For the PROCESS group. The PROCESS 2018 statement: updating consensus preferred reporting of CasE series in surgery (PROCESS) guidelines","volume":"60","author":"Agha","year":"2018","journal-title":"Int. J. Surg."},{"issue":"20","key":"10.1016\/j.amsu.2020.10.061_bib35","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"J. Am. Med. Assoc."},{"issue":"7","key":"10.1016\/j.amsu.2020.10.061_bib36","doi-asserted-by":"crossref","first-page":"102568","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia","volume":"19","author":"Toniati","year":"2020","journal-title":"Italy. Autoimmun Rev."},{"issue":"8","key":"10.1016\/j.amsu.2020.10.061_bib37","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2665-9913(20)30173-9","article-title":"Tocilizumab in patients with severe COVID-19: a retrospective cohort study","volume":"2","author":"Guaraldi","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.amsu.2020.10.061_bib38","article-title":"Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study [published online ahead of print, 2020 Aug 14]","author":"Biran","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"21","key":"10.1016\/j.amsu.2020.10.061_bib39","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","article-title":"Covid-19 in critically ill patients in the seattle region - case series","volume":"382","author":"Bhatraju","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.amsu.2020.10.061_bib40","doi-asserted-by":"crossref","first-page":"2000524","DOI":"10.1183\/13993003.00524-2020","article-title":"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study","volume":"55","author":"Du","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.amsu.2020.10.061_bib41","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"issue":"6","key":"10.1016\/j.amsu.2020.10.061_bib42","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.mayocp.2020.04.006","article-title":"Association between hypoxemia and mortality in patients with COVID-19","volume":"95","author":"Xie","year":"2020","journal-title":"Mayo Clin. Proc."},{"issue":"10239","key":"10.1016\/j.amsu.2020.10.061_bib43","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","article-title":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","volume":"395","author":"Cummings","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.amsu.2020.10.061_bib44","doi-asserted-by":"crossref","first-page":"m1091","DOI":"10.1136\/bmj.m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.amsu.2020.10.061_bib45","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s13054-020-03098-9","article-title":"Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China","volume":"24","author":"Xu","year":"2020","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.amsu.2020.10.061_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1164\/rccm.202004-1226LE","article-title":"Respiratory mechanics of COVID-19- versus non-COVID-19-associated acute respiratory distress syndrome","volume":"202","author":"Haudebourg","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.amsu.2020.10.061_bib47","article-title":"Tocilizumab for treatment of mechanically ventilated patients with COVID-19 [published online ahead of print, 2020 Jul 11]","author":"Somers","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.amsu.2020.10.061_bib48","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/s13063-020-04447-3","article-title":"A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Rilinger","year":"2020","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.amsu.2020.10.061_bib49","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s13063-020-04453-5","article-title":"Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Maes","year":"2020","journal-title":"Trials"},{"issue":"9","key":"10.1016\/j.amsu.2020.10.061_bib50","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/annrheumdis-2020-218479","article-title":"Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study","volume":"79","author":"Ramiro","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.amsu.2020.10.061_bib52","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2028836","article-title":"BACC bay tocilizumab trial investigators. Efficacy of tocilizumab in patients hospitalized with covid-19","author":"Stone","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.amsu.2020.10.061_bib53","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1001\/jama.2020.2783","article-title":"Positive RT-PCR test results in patients recovered from COVID-19","volume":"323","author":"Lan","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.amsu.2020.10.061_bib54","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.amsu.2020.10.061_bib55","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11606-020-05822-1","article-title":"A case series of recurrent viral RNA positivity in recovered COVID-19 Chinese patients. Version 2","volume":"35","author":"Zheng","year":"2020","journal-title":"J. Gen. Intern. Med."},{"issue":"5","key":"10.1016\/j.amsu.2020.10.061_bib56","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.10475","article-title":"Recurrent positive reverse transcriptase-polymerase chain reaction results for coronavirus disease 2019 in patients discharged from a hospital in China","volume":"3","author":"Hu","year":"2020","journal-title":"JAMA Netw Open"}],"container-title":["Annals of Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2049080120304179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2049080120304179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T16:06:29Z","timestamp":1677081989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2049080120304179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":53,"alternative-id":["S2049080120304179"],"URL":"https:\/\/doi.org\/10.1016\/j.amsu.2020.10.061","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series","name":"articletitle","label":"Article Title"},{"value":"Annals of Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amsu.2020.10.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.","name":"copyright","label":"Copyright"}]}}